Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Furosemide is a loop diuretic medication primarily used to treat edema associated with congestive heart failure, liver cirrhosis, kidney disease (including nephrotic syndrome), and hypertension. It works by inhibiting the reabsorption of sodium and chloride in the thick ascending limb of the loop of Henle in the kidneys. This inhibition increases urine production (diuresis), which helps reduce fluid buildup and lower blood pressure. Furosemide can be administered orally as tablets or liquid solution and intravenously or subcutaneously for rapid effect. It was patented in 1959 and approved for medical use in 1964. It is on the World Health Organization's List of Essential Medicines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on furosemide.